Aligning with national efforts to modernise cancer diagnosti...
Andrew Newland, CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.
Newsletters and Deep Dive digital magazine
Andrew Newland, CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.
With stronger foundations and a growing national appetite for change, 2026 could be the year when unified data becomes routine practice.
Digital systems are steadily replacing legacy software and automation tools roll out at speed to cut back the time clinicians spend on manual tasks.
Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.
Simplifying the complexity of medical treatments extends beyond convenience to improving equity.
Editor's Picks
Newsletters and Deep Dive
digital magazine